Genomma Lab Internacional. de Balance Sheet Health
Financial Health criteria checks 5/6
Genomma Lab Internacional. de has a total shareholder equity of MX$9.8B and total debt of MX$6.2B, which brings its debt-to-equity ratio to 63.7%. Its total assets and total liabilities are MX$21.3B and MX$11.5B respectively. Genomma Lab Internacional. de's EBIT is MX$3.3B making its interest coverage ratio 4.7. It has cash and short-term investments of MX$1.1B.
Key information
63.7%
Debt to equity ratio
Mex$6.23b
Debt
Interest coverage ratio | 4.7x |
Cash | Mex$1.14b |
Equity | Mex$9.77b |
Total liabilities | Mex$11.54b |
Total assets | Mex$21.31b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GEKA's short term assets (MX$11.1B) exceed its short term liabilities (MX$6.9B).
Long Term Liabilities: GEKA's short term assets (MX$11.1B) exceed its long term liabilities (MX$4.7B).
Debt to Equity History and Analysis
Debt Level: GEKA's net debt to equity ratio (52%) is considered high.
Reducing Debt: GEKA's debt to equity ratio has reduced from 79% to 63.7% over the past 5 years.
Debt Coverage: GEKA's debt is well covered by operating cash flow (29.1%).
Interest Coverage: GEKA's interest payments on its debt are well covered by EBIT (4.7x coverage).